European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...

CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Patients taking the multiple sclerosis (MS) drug Avonex (search) should be watched for possible liver problems, says the drug’s maker. Rare cases of severe liver injury, including cases of liver ...

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...

Avonex (interferon beta-1a) may not be safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. »Learn more about Avonex, including ...

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...

WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...

Avonex (interferon beta-1a) has potential interactions with other medications. For example, Avonex can interact with certain antiretroviral drugs and monoclonal antibodies. Avonex is used in adults to ...